A Texas woman is suing pharmaceutical giant Wyeth LLC for physical and emotional injuries she claims to have sustained after ingesting the drug Reglan.
The lawsuit was filed May 9 at the Philadelphia Court of Common Pleas by attorney Rosemary Pinto of Feldman & Pinto in Philadelphia. Pinto filed the complaint on behalf of Barbara Hernandez, of Smyer, Texas.
In her lawsuit, Hernandez alleges that her ingestion of the drug Reglan, or its generic form, metoclopramide, from about February 2008 to August 2009, caused her to be diagnosed with Restless Leg Syndrome, Parkinson’s Disease, tremors, extrapyramidal symptoms and emotional distress.
Because of her afflictions, Hernandez has experienced financial loss, the complaint states.
The plaintiff is seeking monetary damages, punitive and/or treble damages, court costs, attorneys’ fees, and other relief as deemed appropriate.
Because her attorney filed what is known as a short form complaint, common in cases awaiting mass tort status, the specifics with regard to monetary damages being sought
were not immediately stated.
The plaintiff has requested a trial by jury.
Named as defendants in the lawsuit are: Wyeth LLC, Wyeth Pharmaceuticals Inc., Wyeth Holdings Corp., Pfizer Inc., Schwarz Pharma Inc., Teva Pharmaceutical USA Inc., Barr Pharmaceuticals LLC, Barr Laboratories Inc., Pliva Inc., and Watson Laboratories Inc.
The case is currently awaiting mass tort listing.
Reglan, and its generic form, metoclopramide, is used to treat reflux-related ailments, such as acid reflux disease, and diabetic gastric stasis.
Numerous lawsuits have been filed nationwide against the makers of the drug.
The case number is 110501052.